University of Alabama at Birmingham
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Alabama at Birmingham sits in the top decile of US sponsors by registered trial count (#26 of 15,742 sponsors by registered trial count).
University of Alabama at Birmingham: 1,160 sponsored US clinical trials, 216 recruiting.
University of Alabama at Birmingham sponsors 1,160 registered US clinical trials on ClinicalTrials.gov, 216 of them currently recruiting, and 723 completed. 97 of these trials are in Phase 3-4 (later-stage) and 259 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 15 trials.
Top-decile sponsor footprint
University of Alabama at Birmingham ranks in the top decile of sponsors by registered trial count (#26 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
723 of 812 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (89.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,160 total, page 3 of 24
Early DHA/ARA Supplementation in Growth-restricted Very Preterm Infants: A Randomized Clinical Trial
NCT06207071
The Impact of Expressive Emotional Writing on Facilitating Grief Resolution in Adults With Spinal Cord Injury
NCT06147258
Refining the Role of Mid-induction Bone Marrow Biopsy in Acute Myeloid Leukemia: A Pilot Study
NCT06323590
Long COVID Brain Fog: Cognitive Rehabilitation Trial
NCT06095297
Chronic Hypertension and Pregnancy 2 (CHAP2) Pilot Project
NCT05989581
Gut Oxalate Absorption in Calcium Oxalate Stone Disease
NCT06331546
O. Formigenes Colonization in Calcium Oxalate Kidney Stone Disease
NCT06330246
Does Fluorescence With or Without Indocyanine Green Improve Parathyroid Identification and Preservation
NCT06169735
Implementation Trial to Evaluate a Population Health Combination Intervention to Meet HIV Testing, Linkage, and Viral Suppression Goals in Alabama
NCT05384145
A Multi-site Feasibility Clinical Trial of Retraining and Control Therapy (ReACT), a Mind and Body Treatment for Pediatric Functional Seizures
NCT05819268
BeFit Toolbox Collaboration: Building Empowerment Through Fitness
NCT06293846
Retraining and Control Therapy (ReACT) R33 Phase
NCT06007053
Multiparametic Metabolic and Hypoxic PET/MRI for Disease Assessment in High Grade Glioma
NCT05632562
Pulsed Lavage in Implant-Based Breast Reconstruction
NCT05585710
High-Intensity Exercise to Combat Vascular and Cognitive Dysfunction in Adults With HIV
NCT05965518
Safety and Efficacy of Carbon Dioxide Gas for Endoscopy
NCT06134154
Usage of Spirometry in Managing IgG Therapy in CVID with Airway Disease
NCT05193552
Stimulus-Evoked Directional Field Potentials to Guide Subthalamic and Pallidal DBS for PD
NCT06169852
Developing an Opioid Taper Intervention Before Total Joint Arthroplasty
NCT05788016
"Embolization Before Ablation of Renal Cell Carcinoma (EMBARC)"
NCT05410509
Molecular Residual Disease (MRD) Guided Adjuvant ThErapy in Renal Cell Carcinoma (RCC)
NCT06005818
Sequential Therapy in Multiple Myeloma Guided by MRD Assessments
NCT05231629
Positron Emission Tomography (PET) Imaging of Neuroinflammation in Patients With Neurological Dysfunction After Severe Acute Respiratory Syndrome Coronavirus 2 (SARS CoV 2) Infection
NCT05656105
Psilocybin-facilitated Treatment for Chronic Pain
NCT05068791
Impact of Gut Microbiome on Metabolic and Bowel Function During the First Year After Spinal Cord Injury
NCT05670288
Making Intergenerational Connections Through Arts
NCT05986149
Quadriceps Tendon Versus Bone Patellar Tendon Bone Autograft ACL Reconstruction RCT
NCT05461326
Cardiometabolic Health Intervention Using Movement-to-Music Exercise
NCT05606432
Cabozantinib and Dostarlimab in Recurrent Gynecologic Carcinosarcoma
NCT05559879
Effect of High-Intensity Exercise to Attenuate Cognitive Function Limitations and Train Exercise Habits in Older People Living With HIV
NCT06013579
Safety and Tolerability of Pirfenidone in Acute Pancreatitis
NCT05350371
Trauma Resuscitation With Low-Titer Group O Whole Blood or Products
NCT05638581
Predicton of Sepsis Recovery Performance Subtypes Pilot Study
NCT05912413
Study of Treatment for HPV16+ ASC-US or LSIL
NCT03913117
Determining the Role of Social Reward Learning in Social Anhedonia
NCT05617898
Oxalate-Driven Host Responses in Kidney Stone Disease
NCT05417568
Telemedicine for Unhealthy Alcohol Use in Persons Living With HIV Using CETA
NCT04955795
Mogamulizumab and Brentuximab Vedotin in CTCL and Mycosis Fungoides
NCT05414500
Describing Treatment Outcomes and Responses in Lymphoma-associated Hemophagocytic Lymphohistiocytosis
NCT05898477
Influence of Metabolic Syndrome on Endogenous Oxalate Synthesis
NCT06735924
Coaching Dementia Caregivers to Master Care-Resistant Behavior
NCT05098652
Constraint-Induced Movement Therapy Plus Sensory Components After Stroke
NCT05515237
The Impact of a Virtual Magic Trick Training Program
NCT05664841
The Nuestros Días ("Our Days") Study
NCT06475534
Investigating Dynamic Interactions in Distributed Cognitive Control Networks
NCT05927974
Functional Outcomes From Diets in Multiple Sclerosis
NCT05327322
State of Hormones Impact Nociceptive Expression
NCT05787470
Stimulation-Induced Changes in Fronto-Limbic Network
NCT05854160
Comparison of 89Zr Panitumumab and (18)F-Fluorodeoxyglucose to Identify Head and Neck Squamous Cell Carcinoma
NCT05183048
The ACHIEVE Trial: Achieving Longer Gestation in Preeclampsia Via Antihypertensive Therapy.
NCT05676476
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 129 |
| Phase 2 | 130 |
| Phase 3 | 25 |
| Phase 4 | 72 |
Therapeutic Areas
What is open in the University of Alabama at Birmingham pipeline
216 recruiting of 1,160 indexed (19% open); 723 completed (62%).
Phase mix: 97 late (III/IV) vs 259 early (I/II) (early-phase heavy).
Top condition: Obesity (15 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Alabama at Birmingham: open-pipeline peers nationwide
Peers matched on 1,160 registered trials and 19% open enrollment, not the therapeutic-area sidebar.
University of Alabama at Birmingham sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,160 trials (± recruiting share)
- NYU Langone Health · 1,164 trials · 17% recruiting
- Wake Forest University Health Sciences · 1,140 trials · 15% recruiting
- Emory University · 1,208 trials · 17% recruiting
- Northwestern University · 1,209 trials · 15% recruiting
Sponsors near 19% open enrollment (± trial volume)
- University of Minnesota · 19% recruiting · 966 trials
- Mclean Hospital · 19% recruiting · 140 trials
- Children's Hospital Medical Center, Cincinnati · 19% recruiting · 571 trials
- Arkansas Children's Hospital Research Institute · 19% recruiting · 97 trials
Related
What to do with this University of Alabama at Birmingham page
1,160 registered trials is a research-attention snapshot, not an endorsement of University of Alabama at Birmingham or any single study.
- 216 of University of Alabama at Birmingham's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition University of Alabama at Birmingham studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of Alabama at Birmingham pipeline card: 1,160 registered trials from official public datasets.Report a data error.